drugset / Trial / NCT01473069

Two Week Study Evaluating Safety, Tolerability and Pharmacokinetics of Multiple Doses of JTK-853 in Healthy Subjects

NCT01473069

Phase 1 Terminated 41 enrolled Akros Pharma Inc.
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study was to determine the safety, tolerability and pharmacokinetics of sequential ascending doses of JTK-853 administered for 14 days in healthy subjects and also to determine the effect of a single dose of ketoconazole on the steady-state pharmacokinetic profile of JTK-853 and its metabolite M2 (one cohort only).

Timeline

Start
2010-03
Primary completion
2010-07
Completion
2010-07

Drugs

EvaluationDrugModalityDoseRoute
Subject JTK-853 Small molecule
Subject Ketoconazole Small molecule

Indications

No indication recorded.